Researchers believe a usually harmless virus could trigger Parkinson’s disease. The Human Pegivirus (HPgV) belongs to the ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.